Connect with us

Technology

Ultima Genomics Major Sequencing Award for Singapore’s National Precision Medicine (NPM) Program Phase III

Published

on

Marks Ultima’s first major win to support a national-scale clinical whole genome sequencing initiativeNPM Phase III will leverage Ultima’s UG200 Platform and recent advancements that enable large-scale applications, including Solaris 2.0 Chemistry, launched in February 2026.Ultima will partner with Lucence, a leading Singapore-based clinical lab offering clinical and oncology applications, and QIAGEN, the leader in technologies enabling end-to-end clinical sequencing workflows

SINGAPORE and FREMONT, Calif., Nov. 2, 2026 /PRNewswire/ — Ultima Genomics, a company offering a new architecture for enabling ultra-high-throughput next generation sequencing, today announced that its UG200 Sequencing Platform has been selected for the SG-INSIGHT study, a cohort under Phase III of Singapore’s National Precision Medicine (NPM) program, a national initiative focused on advancing the integration of genomics into clinical workflows and healthcare delivery. Precision Health Research, Singapore (PRECISE) is the central coordinating office for the NPM program. The award coincides with recent advancements in Ultima’s technology that enable high-quality, large-scale, and low-cost whole genome sequencing, including the launch of Ultima’s UG200 Sequencing Platform and Solaris 2.0 chemistry in February 2026.  Ultima will support the program through a collaboration with Singapore-based Lucence, a Singapore-based precision medicine leader, and QIAGEN, a global leader in Sample to Insight solutions. 

NPM Phase III significantly expands the scale and scope of Singapore’s precision medicine effort to about 450,000 individuals — nearly one in 10 Singapore residents — with a significant shift toward participants receiving medical treatment and healthcare services. Unlike Phase II, which focused on healthy individuals, Phase III includes patients across a wide spectrum of health conditions from Singapore’s three public healthcare clusters: NHG Health, National University Health System (NUHS) and SingHealth. NPM Phase III is intended to generate evidence to support the safe and effective rollout of genetic screening and future integration of genomics into public healthcare.

The selection of Ultima technology as part of the Consortium led by Lucence follows an extensive evaluation process. Throughout the process, Ultima and its consortium partners demonstrated a comprehensive approach that addressed quality, clinical readiness, pricing and innovation using Ultima’s latest technology, including the UG200 system, Solaris 2.0 chemistry, and bioinformatics analytics.  

“This award is an important milestone for Ultima Genomics and demonstrates significant advancements to our platform that unlock whole genome sequencing for clinical applications at scale, at low cost, and with high-quality data.  NPM Phase III’s SG-INSIGHT cohort is an excellent example of how Ultima’s drive towards lower costs can support national-scale precision medicine initiatives across geographies worldwide.  It also shows how the UG200 can enable our customers and partners to support cost-sensitive initiatives,” said Gilad Almogy, Chief Executive Officer of Ultima Genomics. “We are honored to work alongside Lucence and QIAGEN in Singapore and to contribute to a program that is advancing the integration of genomics into healthcare. NPM Phase III’s SG-INSIGHT represents an important opportunity to demonstrate how innovation, collaboration, and operational excellence can accelerate precision medicine at a population scale.”

Under the collaboration, Lucence will provide end-to-end clinical program management and local operational leadership, QIAGEN will support sample preparation and automation workflows, and Ultima will provide sequencing and genomic analysis capabilities designed to enable high-quality, scalable, clinical-grade whole-genome sequencing. Together, the consortium aims to support the successful execution of NPM Phase III and to establish a model for future national genomics initiatives.

The award further strengthens Ultima’s presence in the Asia-Pacific region and underscores the company’s ongoing commitment to advancing population genomics, precision medicine, oncology, rare disease research, and emerging clinical applications across global healthcare systems. SG-INSIGHT is expected to serve as a key reference program as governments, healthcare providers, and research institutions explore broader adoption of precision medicine.

Singapore has established itself as a global leader in biomedical innovation and precision medicine. Through collaboration with local healthcare, research, and industry partners, Ultima aims to contribute to the development of a sustainable genomics ecosystem that supports scientific advancement, clinical innovation, and long-term healthcare impact.

Ultima continues to advance its sequencing and analysis capabilities to support clinical whole genome sequencing at population scale. These efforts include the recent launch of paired-end sequencing and the development of pangenome-aware WGS analysis, which is expected to be available by year-end 2026. Together, these capabilities will expand the flexibility of Ultima’s technology for whole-genome and other large-scale sequencing applications.

https://www.ultimagenomics.com/

About Ultima Genomics

Ultima Genomics is unleashing the power of genomics at scale. The Company’s mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultima’s revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information, and catalyze the next phase of genomics in the 21st century. To learn more, visit www.ultimagenomics.com.

About Precision Health Research, Singapore (PRECISE)

Precision Health Research, Singapore (PRECISE) leads the National Precision Medicine (NPM) programme, advancing genomics to improve health and grow Singapore’s biomedical sector. Phase II sequenced 100,000 Singaporeans, while Phase III, in partnership with Singapore’s three healthcare clusters, is evaluating how genomics can be integrated into clinical care responsibly. 

PRECISE is a programme of the Consortium for Clinical Research and Innovation, Singapore (CRIS). NPM Phase II is supported by the National Research Foundation, Singapore under the White Space funding (MOH-000588 and MOH-001264) and administered by the Singapore Ministry of Health (MOH) through the National Medical Research Council (NMRC) Office, MOH Holdings Pte Ltd. NPM Phase III is supported by the Singapore MOH through the NMRC Office, MOH Holdings Pte Ltd under the NMRC NPM Phase III Funding Initiative (MOH-001734). 

www.npm.sg

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding anticipated benefits from participation in Singapore’s National Precision Medicine Program, the expected impact of the NPM Phase III initiative, future sequencing volumes and program expansion opportunities, advancement of precision medicine, growth opportunities in Asia-Pacific and other regions, development of future collaborations, and potential clinical and commercial applications of Ultima’s technologies. These forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that may affect actual results include program timelines, regulatory developments, market conditions, clinical validation outcomes, operational execution, technological performance, and other risks associated with the commercialization and adoption of genomic technologies. Ultima Genomics undertakes no obligation to update forward-looking statements except as required by applicable law.

mailto:ir@ultimagenomics.com

Media Contact
Vikki Herrera
Oak Street Communications for Ultima Genomics
vikki@oakstreetcommunications.com
408-206-7009

View original content to download multimedia:https://www.prnewswire.com/news-releases/ultima-genomics-major-sequencing-award-for-singapores-national-precision-medicine-npm-program-phase-iii-302926879.html

SOURCE Ultima Genomics

Continue Reading

Technology

Deloitte named a Leader in IDC MarketScape Worldwide AI-enabled Adobe Professional Services 2026 Vendor Assessment

Published

on

By

This report is a quantitative and qualitative assessment of the characteristics that explain a vendor’s success in the marketplace

NEW YORK, Nov. 5, 2026 /PRNewswire/ — Deloitte has been positioned as a Leader in the IDC MarketScape Worldwide AI-Enabled Adobe Professional Services 2026 Vendor Assessment (Doc #US54114626, October 2026). Deloitte is recognized as a “worldwide services provider that combines a long heritage in business consulting with broad and deep IT services capabilities, and with a strong understanding of its clients’ business on multiple levels.” Deloitte’s Adobe-focused professional services are delivered through Deloitte Digital.

This assessment was produced by “key findings from IDC’s 56 calls with reference clients of Adobe professional services.” This IDC MarketScape evaluation “is based on a comprehensive framework and set of parameters expected to be most conducive to success in providing professional services relating to AI-enabled Adobe professional services in both the short term and the long term.” Deloitte was positioned as a Leader of the IDC MarketScape: Worldwide Experience Design Services 2025 Vendor Assessment (Doc #US52973225, October 2025) and the IDC MarketScape: Worldwide Experience Build Services 2025 Vendor Assessment (Doc #US52973125, October 2025). 

“We’re honored to be recognized by IDC MarketScape as a Leader in the 2026 Worldwide AI-Enabled Adobe Professional Services Vendor Assessment,” says Kim Frazier, Deloitte Global Chief Commercial Officer, Adobe Alliance. “As technology reshapes customer expectations, our deep knowledge of Adobe solutions and forward deployed models help organizations respond quickly and turn new possibilities into meaningful outcomes. We’ll continue building on the strength of our alliance and the innovation of our teams to help clients realize greater value from their investments.”

“Organizations today are looking for collaborators who can bring together creativity, technology, data, and industry insight to drive meaningful business outcomes,” says Mark Lush, Deloitte Global Consulting Services Customer Offering Portfolio leader and Global Head of Deloitte Digital. “We’re proud of this recognition, which I believe reflects Deloitte Digital’s dedication to helping clients create exceptional customer experiences, accelerate growth, and realize the potential of AI-powered transformation.”

“Adobe and Deloitte have built a strong relationship around a shared focus on customer outcomes,” says Kyle Ellis, Global Vice President & General Manager, Strategic Partnership Program, Adobe. “Deloitte brings a thoughtful, practical approach to complex experience challenges, helping organizations put Adobe’s AI-powered technology to work in ways that strengthen their brands, engage customers, and drive growth.”

According to the IDC MarketScape:

“Based on conversations with Deloitte’s clients, the three main areas where clients commended Deloitte were people quality, value creation, and Adobe-specific thought leadership.”

“Deloitte’s breadth and depth of capabilities, and its ability to mobilize its people quickly on a global scale, are important capabilities for clients.”

“Since 2021, Deloitte has won 10 global Adobe Digital Experience Partner or Customer Experience Orchestration Partner awards, has had 16 of its employees appointed as Adobe Community Advisors, and has been a Diamond sponsor of Adobe Summit every year.”

“Deloitte Digital has a number of intellectual property assets to help its clients drive value from Adobe technology, including:Connected Studio Powered by Adobe: An Accredited Solution combining Adobe’s Creative and Experience Cloud platforms with Deloitte Digital’s technical, operational, and creative expertise, including Workfront, to help clients create more content, faster and for less, in a real-time market.

Deloitte Digital Dual Zone: An Accredited Solution that resolves pre-ingestion data hygiene and identity resolution issues, helping clients build complete, consistent customer profiles and unified data sets from multiple platforms and target market segments from a complete view of customers.

Adobe Xccelerator (AX): An Accredited Solution providing a production-ready platform and a suite of reusable components, templates, features, and integrations that extend Adobe Experience Manager, giving clients faster time to value on Adobe’s digital platforms.

Closed-Loop Marketing Solution: A closed-loop marketing (CLM) Accredited Solution that combines marketing automation and financial management for more cost-efficient marketing (Customers using this solution are able to track more than performance of content based on click-throughs, since this solution tracks actual ROI of content and campaigns).

Investment to Value Map: A tool to help CMOs strategically transform and modernize the marketing function.

ConvergeCONSUMER™: A tool that combines Deloitte’s proprietary consumer data with applied AI and machine learning to help organizations know their customers, predict demand, and personalize experiences.

IndustryAdvantage™: An industry-benchmarking framework Deloitte draws on when building clients’ marketing transformation road maps, including competitive analysis, a marketing capability maturity model, and a multiyear business case and road map.”

For more information about Deloitte Analyst Relations, please visit our Analyst Relations page.

About IDC MarketScape
IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each supplier’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of technology suppliers can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective suppliers.

About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (DTTL), its global network of member firms, and their related entities (collectively, the “Deloitte organization”). DTTL (also referred to as “Deloitte Global”) and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more.

Deloitte provides leading professional services to nearly 90% of the Fortune Global 500® and thousands of private companies. Our people deliver measurable and lasting results that help reinforce public trust in capital markets and enable clients to transform and thrive. Building on its 180+-year history, Deloitte spans more than 150 countries and territories. Learn how Deloitte’s nearly 500,000 people worldwide work together every day to make an impact that matters at www.deloitte.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/deloitte-named-a-leader-in-idc-marketscape-worldwide-ai-enabled-adobe-professional-services-2026-vendor-assessment-302930819.html

SOURCE Deloitte Global

Continue Reading

Technology

HUSK Launches All-in-One Ecosystem, Uniting Healthy Living and Clinical Care in a Single Platform

Published

on

By

New offering connects health plan-covered nutrition and mental health care with a personalized engagement journey — giving employers a way to measure whether wellness spend is reducing healthcare costs

WAYNE, Pa., Nov. 5, 2026 /PRNewswire/ — In both self-funded and fully insured health plans, most employees already have access to registered dietitians and licensed therapists, yet much of that care goes unused. Today, HUSK, a preventative wellness technology company serving self-funded and fully insured employers and health insurers, announced the launch of its all-in-one wellness ecosystem, HUSK Wellness. The all-in-one ecosystem brings healthy living programs and clinical care together in a single personalized experience, with outcomes reporting employers can act on.

For three decades, HUSK has helped employers engage their workforces in wellness. In that time, it has seen the same gap again and again. Benefits are spread across separate vendors, covered care goes unused, and employers have no reliable way to connect wellness spend to outcomes. HUSK Wellness closes that gap by building each employee a personalized journey across five benefits: Challenge, Rewards, Marketplace, Nutrition and Mental Health. Each journey is shaped by employer goals and driven by employee choice.

“Employers have spent years buying wellness one vendor at a time, and the result is benefits that sit unused and no clear line to healthcare costs,” said Erin Markowski, President and CEO of HUSK. “The clinical care is already covered by the health plan, whether an employer is fully insured or self-funded. Our job is to connect it to the healthy habits people enjoy, so employees actually use it and employers can finally see whether their wellness investment is reducing healthcare spend.” — Erin Markowski, President & CEO of HUSK

The HUSK Wellness journey begins with onboarding led by Poppie, HUSK’s wellness assistant. Poppie learns each employee’s goals, interests and preferences, then builds a personalized path across all five benefits. Because everything lives in one connected ecosystem, employees spend less time searching and more time engaging. Employers can see utilization, ROI, and how participation relates to high-cost utilization such as ER visits and chronic condition spend.

“Most wellness platforms are built to nudge people into engagement. We built ours around choice,” said Samantha Chase, Head of Product at HUSK. “Employees tell Poppie what they care about, and the platform builds a journey around that. People stick with what they chose for themselves.” — Samantha Chase, Head of Product at HUSK

HUSK Wellness is available now to employers and health insurance partners. Employers can request a walkthrough at https://huskwellness.com/.

About HUSK Wellness

HUSK Wellness is a preventative wellness technology company serving employer clients and health insurers. Operating under parent company Volaris, HUSK combines engagement solutions (Rewards, Challenge, and Marketplace) with clinical care delivered by Registered Dietitians and Mental Health Therapists. Learn more at huskwellness.com.

Media Contact
Keri Lindenmuth
Product Marketing Manager
klindenmuth@huskwellness.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/husk-launches-all-in-one-ecosystem-uniting-healthy-living-and-clinical-care-in-a-single-platform-302929725.html

SOURCE Husk

Continue Reading

Technology

Listrak Debuts Integration with Dataships, Creating a Connected Approach to Compliance and Growth

Published

on

By

Consent collected through Dataships now flows into Listrak automatically, with each subscriber’s opt-in type preserved.

LITITZ, Pa., Nov. 5, 2026 /PRNewswire/ — Listrak, the cross-channel personalization platform, today announced its new integration with consent optimization platform Dataships. Dataships and Listrak work together to help consumer brands grow their direct marketing audiences while maintaining compliant consent practices across regions.

Dataships optimizes how marketing consent is collected across forms, checkout, confirmation pages, and other collection points, showing each shopper the appropriate consent experience based on factors like location, consent history, and applicable regulations. Through the Listrak integration, subscribers and their consent status collected through Dataships flow directly into Listrak, with no manual exports or imports, allowing brands to activate those audiences across their marketing programs. Single opt-in contacts are subscribed right away, double opt-in contacts receive Listrak’s confirmation email, and unsubscribes in Listrak sync back to Dataships, so consent records stay aligned on both platforms. 

Use cases of the Listrak + Dataships integration include:

Consent optimization. Dataships optimizes forms, checkout, confirmation pages, and anywhere else direct marketing consent is collected, showing every shopper the right ask based on their location, consent history, language preference, and more, which helps brands grow email audiences from their customers.Consent compliance. As each ask is optimized for growth, compliance is enforced underneath so no ask that could bring a brand out of compliance is shown. Opt-ins are stored as a permanent timestamped record, so brands stay compliant everywhere they sell and can prove exactly who they can legally reach.Consent intelligence. Dataships measures how marketing consent performs across channels, markets, and collection points and provides benchmarks, so brands understand the impact marketing consent has on their business, including audience growth, incremental revenue, and overall compliance posture.

“Since growing your audience and staying compliant go together, consent should follow the shopper into the marketing platform automatically,” said Leah Beitler, VP of Partnerships & Ecosystems, Listrak. “With Listrak’s compliance center of excellence combined with Dataships’ consent expertise, retailers grow their lists by increasing opt-ins across channels while staying aligned with regional rules.”

“Dataships is built on the belief that compliance is the infrastructure for growth,” said Matt Gottron, Head of Growth, Dataships. “Through our Listrak integration, retailers access a connected approach to audience growth, compliance, and retention marketing, which results in increased long-term customer value.”

About Listrak

Listrak is the cross-channel personalization platform for retail. By unifying customer data, identity, AI, and cross-channel marketing in one platform, Listrak enables retailers to deliver relevant, personalized experiences across email, SMS, RCS, app, web, and in-store. Listrak helps brands win new customers, increase engagement, drive conversions, strengthen loyalty, and grow revenue. Listrak publishes quarterly retail marketing benchmarks, drawn from data across its platform, at https://www.listrak.com/quarterly-benchmarks. For more information, visit https://www.listrak.com/.

About Dataships

Dataships is a marketing consent optimization platform for consumer brands. We optimize forms, checkout, confirmation pages, and anywhere else direct marketing consent is collected to help brands grow email, SMS, and WhatsApp audiences, stay compliant wherever they sell, and understand the impact marketing consent has on their business. For more information, visit https://www.dataships.io/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/listrak-debuts-integration-with-dataships-creating-a-connected-approach-to-compliance-and-growth-302930963.html

SOURCE LISTRAK

Continue Reading

Trending